Variant report
Variant | nsv945299 |
---|---|
Chromosome Location | chr1:220487822-220491617 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:29)
- CpG islands (count:0)
- Chromatin interactive region (count:2)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:29 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr1:220490593-220490793 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr1:220491114-220491314 | HepG2 | liver: | n/a | n/a |
3 | CEBPB | chr1:220491119-220491179 | Hela-S3 | cervix: | n/a | n/a |
4 | CTCF | chr1:220489400-220489550 | GM12878 | blood: | n/a | n/a |
5 | E2F4 | chr1:220488199-220488393 | MCF10A-Er-Src | breast: | n/a | n/a |
6 | FOS | chr1:220488480-220488727 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | FOS | chr1:220488408-220488941 | MCF10A-Er-Src | breast: | n/a | n/a |
8 | FOS | chr1:220489284-220489579 | MCF10A-Er-Src | breast: | n/a | chr1:220489337-220489348 chr1:220489334-220489345 chr1:220489462-220489471 chr1:220489336-220489344 |
9 | FOS | chr1:220489326-220489459 | MCF10A-Er-Src | breast: | n/a | chr1:220489337-220489348 chr1:220489334-220489345 chr1:220489336-220489344 |
10 | FOS | chr1:220488505-220488735 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | FOS | chr1:220489314-220489524 | MCF10A-Er-Src | breast: | n/a | chr1:220489337-220489348 chr1:220489334-220489345 chr1:220489462-220489471 chr1:220489336-220489344 |
12 | FOS | chr1:220488442-220488795 | MCF10A-Er-Src | breast: | n/a | n/a |
13 | GATA3 | chr1:220489171-220489669 | SK-N-SH | brain: | n/a | chr1:220489496-220489503 chr1:220489478-220489487 chr1:220489496-220489503 chr1:220489496-220489503 |
14 | HEY1 | chr1:220490239-220490518 | K562 | blood: | n/a | n/a |
15 | JUN | chr1:220490949-220491068 | HepG2 | liver: | n/a | chr1:220490984-220490993 chr1:220490980-220490993 |
16 | JUND | chr1:220490878-220491123 | HepG2 | liver: | n/a | chr1:220490984-220490993 |
17 | MYC | chr1:220488400-220488729 | MCF10A-Er-Src | breast: | n/a | n/a |
18 | MYC | chr1:220488432-220488721 | MCF10A-Er-Src | breast: | n/a | n/a |
19 | POLR2A | chr1:220490170-220490340 | H1-hESC | embryonic stem cell: | n/a | n/a |
20 | POLR2A | chr1:220490049-220490502 | H1-hESC | embryonic stem cell: | n/a | n/a |
21 | POLR2A | chr1:220490060-220490617 | GM12878 | blood: | n/a | n/a |
22 | POLR2A | chr1:220490305-220490320 | H1-hESC | embryonic stem cell: | n/a | n/a |
23 | POLR2A | chr1:220490115-220490494 | H1-hESC | embryonic stem cell: | n/a | n/a |
24 | POLR2A | chr1:220490665-220490688 | GM12878 | blood: | n/a | n/a |
25 | POLR2A | chr1:220488201-220488287 | MCF10A-Er-Src | breast: | n/a | n/a |
26 | POLR2A | chr1:220489165-220489239 | MCF10A-Er-Src | breast: | n/a | n/a |
27 | STAT3 | chr1:220488474-220488766 | MCF10A-Er-Src | breast: | n/a | n/a |
28 | STAT3 | chr1:220488501-220488674 | MCF10A-Er-Src | breast: | n/a | n/a |
29 | STAT3 | chr1:220488426-220488758 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:2 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ENSG00000232883 | TF binding region |
XRCC6P3 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs142025466 | chr1:220487832-220487833 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550251003 | chr1:220487852-220487853 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570160021 | chr1:220487888-220487889 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs80190668 | chr1:220487891-220487892 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs150716161 | chr1:220487913-220487914 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs190560045 | chr1:220487923-220487924 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs566094820 | chr1:220487930-220487931 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs534586430 | chr1:220487968-220487969 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs139503147 | chr1:220487976-220487977 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs577725025 | chr1:220488038-220488039 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs536854321 | chr1:220488058-220488059 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs370947355 | chr1:220488062-220488063 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs556786750 | chr1:220488113-220488114 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs573382562 | chr1:220488134-220488135 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs542338772 | chr1:220488167-220488168 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192711707 | chr1:220488184-220488185 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs6702901 | chr1:220488188-220488189 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
18 | rs541321495 | chr1:220488196-220488197 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs375669015 | chr1:220488216-220488217 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs564804053 | chr1:220488238-220488239 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs533501360 | chr1:220488240-220488241 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550387535 | chr1:220488281-220488282 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs563906892 | chr1:220488318-220488319 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs573105378 | chr1:220488330-220488331 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs529385223 | chr1:220488338-220488339 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs6694670 | chr1:220488354-220488355 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs111916427 | chr1:220488446-220488447 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs535028842 | chr1:220488462-220488463 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs147155632 | chr1:220488523-220488524 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs571518966 | chr1:220488564-220488565 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs184370206 | chr1:220488566-220488567 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs140424698 | chr1:220488571-220488572 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs573520610 | chr1:220488593-220488594 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs535907752 | chr1:220488621-220488622 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs553040819 | chr1:220488634-220488635 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs572701682 | chr1:220488642-220488643 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs544985557 | chr1:220488690-220488691 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs564768408 | chr1:220488707-220488708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs35412340 | chr1:220488715-220488716 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs561645358 | chr1:220488726-220488727 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs149713578 | chr1:220488734-220488735 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs544155835 | chr1:220488735-220488736 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs530665837 | chr1:220488736-220488737 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs189692824 | chr1:220488752-220488753 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529529143 | chr1:220488796-220488797 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs145583683 | chr1:220488813-220488814 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs148479619 | chr1:220488904-220488905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs550285808 | chr1:220488912-220488913 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs528627355 | chr1:220488954-220488955 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs551746087 | chr1:220488970-220488971 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Schizophrenia | 19415332 | CNVD |
Autism | 22495311 | CNVD |
Melanoma | 18172304 | CNVD |
Rett syndrome | 21593744 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 17443227 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 17133270 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Cervical cancer | 21063398 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 20632083 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Medulloblastoma | 21292688 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Breast cancer | 21264507 | CNVD |
Liposarcoma | 21253554 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Cancer | 16751803 | CNVD |
Prostate cancer | 16705090 | CNVD |
Neuroblastoma | 19435921 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16461572 | CNVD |
Intracranial tumor | 16823260 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Neuroblastoma | 21899760 | CNVD |
Breast cancer | 21858162 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Breast cancer | 16608533 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Breast cancer | 17001317 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ependymoma | 18628472 | CNVD |
Leukemia | 18628472 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 19100363 | CNVD |
Breast cancer | 21509527 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Chordoma | 18071362 | CNVD |
Multiple myeloma | 16461302 | CNVD |
van der Woude syndrome | 22470819 | CNVD |
van der Woude syndrome | 20818247 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Urothelial tumor | 18831757 | CNVD |
Lung cancer | 18438408 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Ovarian clear cell carcinoma | 19293255 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Basal cell lymphoma | 17170743 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Congenital diaphragmatic hernia | 21085971 | CNVD |
Holoprosencephaly | 19184110 | CNVD |
Breast cancer | 21069454 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Mental retardation | 19951919 | CNVD |
Non-syndromic sensorineural hearing loss | 17873649 | CNVD |
Acute myeloid leukemia | 17268525 | CNVD |
Lung cancer | 16740712 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Developmental delay | 21147756 | CNVD |
Pleomorphic liposarcoma | 18784837 | CNVD |
Autism | 14699429 | CNVD |
Breast cancer | 21364760 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Tetralogy of Fallot | 22912587 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr1:220486200-220488600 | Weak transcription | Foreskin Melanocyte Primary Cells skin01 | Skin |
2 | chr1:220487000-220488400 | Enhancers | Right Ventricle | heart |
3 | chr1:220487400-220495400 | Weak transcription | Right Atrium | heart |
4 | chr1:220487800-220489600 | Enhancers | Fetal Heart | heart |
5 | chr1:220488200-220488800 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
6 | chr1:220488200-220490800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr1:220488400-220488800 | Enhancers | Left Ventricle | heart |
8 | chr1:220488400-220490200 | Enhancers | Adipose Nuclei | Adipose |
9 | chr1:220488400-220490200 | Weak transcription | Right Ventricle | heart |
10 | chr1:220488600-220489400 | Enhancers | Foreskin Melanocyte Primary Cells skin01 | Skin |
11 | chr1:220488800-220489600 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
12 | chr1:220488800-220491800 | Weak transcription | Left Ventricle | heart |
13 | chr1:220489000-220489600 | Enhancers | NHDF-Ad | bronchial |
14 | chr1:220489600-220491200 | Weak transcription | Fetal Heart | heart |
15 | chr1:220490200-220490600 | Enhancers | Right Ventricle | heart |
16 | chr1:220490200-220492400 | Weak transcription | Adipose Nuclei | Adipose |
17 | chr1:220490600-220491600 | Weak transcription | Right Ventricle | heart |
18 | chr1:220490800-220491200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr1:220491200-220491400 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
20 | chr1:220491200-220493000 | Enhancers | Fetal Heart | heart |
21 | chr1:220491400-220492400 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
22 | chr1:220491600-220492000 | Enhancers | HSMMtube | muscle |